Skip to main content
HairCited

Acides gras oméga-3 pour Telogen Effluvium

B

Basé sur 11 études avec 317 participants au total. 8/11 études montrent des effets positifs.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Domega\u002D3\u0026condition\u003Dtelogen\u002Deffluvium'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

En conclusion

Moderate evidence suggests that omega-3 fatty acids may help support hair recovery in telogen effluvium, though the research base is limited and they are usually studied alongside other nutrients.

  • 8 out of 11 studies show positive effects, but total sample size is small (317 participants)
  • Often studied as part of multi-nutrient supplement formulations
  • No large-scale RCTs specifically for omega-3 and telogen effluvium
  • May support recovery through anti-inflammatory and nutritional mechanisms

Key Study Findings

review
Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations.
Dose: Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 vs: Placebo Effet: Comparable efficacy to topical minoxidil; hypertrichosis 24%, shedding 16-22%, peripheral edema 2% None
narrative review
Herbal Remedies for Hair Loss: A Review of Efficacy and Safety.
Dose: varies by remedy and study vs: Placebo Effet: None None
scoping_review n=16
A Scoping Review of Exosome Delivery Applications in Hair Loss.
Dose: variable; exosomes predominantly from mesenchymal stem cells (MSCs) vs: Placebo Effet: None None
review
The Use of Light-Based Therapies in the Treatment of Alopecia.
Dose: Low-level light therapy (LLLT) various devices and wavelengths; combined with minoxidil or finasteri vs: Placebo Effet: LLLT improves hair density in AGA; potential to prolong anagen phase in telogen effluvium; may promo None
Cohort n=200 Open-label
Iron Supplementation May Improve the Patient's Level of Satisfaction in Not-Low-Ferritin Telogen Effluvium: A Real-Life …
Dose: high dose elemental iron (dose unspecified) vs: Placebo Effet: Patients with baseline ferritin ≥50 ng/ml mostly 'very satisfied'; patients with ferritin <50 ng/ml None

Key Statistics

11

Études

317

Participants

Positive

B

Note

Referenced Papers

Skin appendage disorders 2025 7 citations
Acta dermatovenerologica Croatica … 2016 6 citations
Therapeutische Umschau. Revue … 2002 4 citations
Dermatologic clinics 1993 38 citations

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Posologies couramment utilisées

general:
250-500 mg EPA+DHA/day
hairloss:
1,000-2,000 mg/day

Limite supérieure : 3,000 mg/day EPA+DHA

Posologies étudiées dans la recherche

Posologie Durée Effet N
Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 -- Positive --
varies by remedy and study -- Positive --
variable; exosomes predominantly from mesenchymal stem cells (MSCs) -- Positive 16
Low-level light therapy (LLLT) various devices and wavelengths; combined with minoxidil or finasteri -- Positive --
high dose elemental iron (dose unspecified) -- Positive 200
None -- Positive --
None -- Neutral 100
psychiatric and dermatological management -- Neutral 1

Moment optimal de prise : With meals containing fat for optimal absorption; split doses if over 1,000 mg

Safety & Side Effects

Effets indésirables signalés

  • Fishy aftertaste or burping
  • Mild gastrointestinal upset (nausea, diarrhea)
  • Possible increased bleeding time at high doses
  • Unpleasant body odor at very high doses

Interactions connues

  • Anticoagulants (warfarin) and antiplatelet drugs (may increase bleeding risk)
  • Blood pressure medications (additive hypotensive effect)
  • Orlistat (reduces omega-3 absorption)

Apport maximal tolérable : 3,000 mg/day EPA+DHA

Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.

Frequently Asked Questions

Does Acides gras oméga-3 help with Telogen Effluvium?
Based on 11 studies with 317 participants, there is moderate evidence from clinical studies that Acides gras oméga-3 may support Telogen Effluvium management. Our evidence grade is B (Good Evidence).
How much Acides gras oméga-3 should I take for Telogen Effluvium?
Studies have used various dosages. A commonly studied range is 250-500 mg EPA+DHA/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Acides gras oméga-3?
Reported side effects may include Fishy aftertaste or burping, Mild gastrointestinal upset (nausea, diarrhea), Possible increased bleeding time at high doses, Unpleasant body odor at very high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Acides gras oméga-3 and Telogen Effluvium?
We rate the evidence as Grade B (Good Evidence). This rating is based on 11 peer-reviewed studies with 317 total participants. The overall direction of effect is positive.

Related Evidence

Acides gras oméga-3 pour d'autres pathologies

Avertissement FDA: Ces déclarations n'ont pas été évaluées par la Food and Drug Administration. Les produits et informations sur ce site ne sont pas destinés à diagnostiquer, traiter, guérir ou prévenir quelque maladie que ce soit. Les notes de preuve présentées sont basées sur notre analyse de la recherche publiée et évaluée par des pairs et ne constituent pas un avis médical. Consultez toujours votre professionnel de santé avant de commencer tout régime de compléments alimentaires.